The MONET team has collaborated on the publication of an ACS Cent Sci paper detailing a new structurally based representation system that is capable of handling the stochastic nature of polymers.

The MONET team has collaborated on the publication of an ACS Cent Sci paper detailing a new structurally based representation system that is capable of handling the stochastic nature of polymers.
Dr. Shangguo Hou of the Welsher lab has developed an adaptive real-time 3D single particle tracking method which can capture the binding events of single viruses to the surface of live cells.
The labs of Professors Michael Therien and David Beratan have collaborated to engineer polarized excited states to "U-Turn" electron transfer.
A team effort by the Derbyshire lab has led to the identification of human genes and pathways that facilitate the infection of liver cells by Plasmodium parasites, the causative agents of malaria.
Knowledge of metal-trafficking processes can be leveraged to develop small molecules that help cells regain metal homeostasis for optimal cellular function or conversely that push cells away from homeostasis and into cellular distress.
A team led by Professors Jiyong Hong and Pei Zhou has discovered a small molecule drug that can stop cancer cells from becoming resistant to chemotherapy.
The Malcolmson lab has demonstrated that conjugated enynes undergo efficient and selective intermolecular 1,4-hydroamination to afford chiral allenes with a variety of primary and secondary aliphatic amines as well as benzophenone imine as an ammonia surrogate.
Lizzie Hunsaker of the Franz lab has discovered that modulating copper levels in the growth environment of Candida albicans reduces tolerance of this pathogen to widely prescribed azole antifungal drugs.
The Malcolmson lab has demonstrated that internal dienes may undergo regio- and enantioselective additions of enolate pronuclephiles.
Rene Raphemot, Amber Eubanks, and other members of the Derbyshire lab, in collaboration with the Haystead lab in the Pharmacology department, have discovered the first reported inhibitors of an atypical Plasmodium kinase - PK9.